banner-link-medical-2

Industries

Biotech

End-to-End Biotech Expertise

LINK Medical offers biotech companies a complete, in-house service model—from early strategy to full clinical execution. With 30+ years of experience, 800+ studies, and strong expertise in CNS, oncology, metabolic and cardiovascular diseases, we support you with clarity, quality and reliable delivery. Whether you need QA support or full end-to-end services, we scale with your project from Phase I–IV across the Nordics and internationally. Benefit from our Strategic Advisory Group sessions and our strong Nordic site network, including our own trial sites in Turku and Helsinki.

pexels-benoît-le-rouge-18647959

Strategic and Scientific Advice

The path to a mature product is long and complex, with many strategic choices and potential pitfalls—especially in the early stages. Knowing which questions to ask and how to shape your product profile is critical for an efficient development strategy.

That’s why we offer a free session with our cross-functional Strategic Advice Group. Led by our Medical Director and senior experts, the group works in close partnership with you to clarify priorities, assess risks, and provide guidance to reduce time, costs, and resource waste in product development.

  • USP or sub service
  • USP or sub service
  • USP or sub service
Group of business people and software developers working as a te

Drug Development /
Pre-Marketing Regulatory Services

Developing a new biotech product can be complex, especially when navigating regulatory requirements before clinical trials. Let LINK Medical’s Nordic regulatory experts guide your team.

We support biotech companies through every stage of early development—from CMC (Chemistry, Manufacturing & Controls) to non-clinical and clinical phases. Our experts ensure your strategy meets current standards, minimizes risks, and accelerates your path to first-in-human studies and beyond.

  • USP or sub service
  • USP or sub service
  • USP or sub service
pexels-alphatradezone-5831696

Full-Service Phase II-IV Clinical Trials

LINK Medical CRO brings advanced expertise in clinical trial methodology across all phases, for any indication or level of complexity. Our regulatory team provides strong support for biotech companies, covering both pre- and post-marketing services, including CMC and compliance review.

  • USP or sub service
  • USP or sub service
  • USP or sub service
pexels-helena-jankovičová-kováčová-18619026

Early Phase FIH /
Phase I Clinical Trial Package

With our two in-house, state-of-the-art clinical research units, we offer full-service Phase I trial packages—from study design to final reports—backed by 30+ years of experience.

Our Phase I expertise covers clinical pharmacology studies in healthy volunteers and patients, for small-molecule NCEs, biologics, and vaccines. We deliver tailored solutions while providing the scientific, clinical, and regulatory expertise needed to achieve study objectives successfully.

  • USP or sub services
  • USP or sub services
  • USP or sub services

590 +

clinical trials

150 +

employees

20 +

therapeutic areas

6

countries

Get in touch

How can we help you?

Contact us and we will tell you more